David Hwang is a pathologist at UHN and an Associate Professor in the Department of Laboratory Medicine & Pathobiology at the University of Toronto. He completed MD and PhD degrees at the University of Toronto, followed by residency training in Anatomical Pathology. Complementing his clinical practice in pulmonary pathology, his primary research focus is in pulmonary infectious disease. He is currently funded by the National Sanitarium Association to study bacterial community-wide gene expression and its role in antibiotic responses and resistance in the cystic fibrosis lung. He is a member of CIHR Emerging Teams investigating nanotechnology-enabled diagnosis and treatment (led by Dr. Gang Zheng, UHN) and engaged in metagenomic profiling of the cystic fibrosis lung (led by Dr. David Guttman, University of Toronto). In addition to research in pulmonary infections, Dr. Hwang is also involved in lung transplantation and repair research in collaboration with investigators of the Latner Thoracic Research Laboratories and with investigators from the Toronto Lung Transplant Program.
David M Hwang
J Thorac Oncol. 2018 Mar 10;:
Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.
Oncotarget. 2018 Feb 02;9(9):8489-8501
Cancer Cell. 2018 Feb 12;33(2):244-258.e10
Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance.
FEMS Microbiol Lett. 2018 Feb 01;:
Evaluations of the tongue and hyoid bone positions and pharyngeal airway dimensions after maxillary protraction treatment.
Cranio. 2018 Jan 12;:1-9
J Heart Lung Transplant. 2017 Oct 02;:
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Lancet Oncol. 2017 Oct 16;:
J Thorac Oncol. 2017 May 09;:
Curr Oncol. 2017 Apr;24(2):103-110
The potential roles of radionanomedicine and radioexosomic in prostate cancer research and treatment.
Curr Pharm Des. 2017 Feb 16;:
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Laboratory Medicine & Pathobiology, University of Toronto